NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present at the World Immunotherapy Congress in San Diego
INmune Bio (NASDAQ: INMB) this morning announced that the company’s co-founders, R.J. Tesi, M.D., and Mark Lowdell, Ph.D., are presenting at the World Immunotherapy Congress USA during the Festival of Biologics San Diego, taking place from March 3rd to 5th. Dr. Tesi and Dr. Lowdell serve as the company’s chief executive office and chief scientific officer, respectively. The World Immunotherapy Congress USA connects leaders and innovators of the international immunotherapy industry to discuss the latest in leading-edge ideas and approaches. The event takes place during the Festival of Biologics San Diego, a collection of four biotechnology and healthcare conferences including…







